Optimizing Novel Tools to Validate Orphan GPCR Targets
Time: 3:30 pm
day: Day One
Details:
- Novel ligands and animal models to validate GPR35 and GPR84 as therapeutic targets
- Use of ‘human specific’ ligands
- Activation state biomarkers for poorly characterized GPCRs